A Review On The Role Of Lekhana And Medohara Plants From Nighantus In Preventing And Managing Sthoulya (Obesity)
Keywords:
Sthoulya, Obesity, Lekhana, Medohara, Nighantu, Ayurvedic Pharmacology, DravyagunaAbstract
Obesity, or Sthoulya, has emerged as a major global public health issue, characterized by abnormal or excessive fat accumulation and associated with increased morbidity and mortality. It contributes significantly to non-communicable diseases such as diabetes mellitus, cardiovascular disorders, osteoarthritis, and certain cancers. Modern medical approaches often focus on pharmacological interventions and bariatric surgeries, which may have limitations and side effects. Ayurveda, the ancient science of life, offers a holistic understanding of obesity, classifying it as a Santarpanajanya Vyadhi, primarily resulting from Kapha Dosha and Medo Dhatu vitiation. Ayurvedic texts emphasize the use of drugs with Lekhana (scraping), Medohara (fat-reducing), and Karshana (slimming) properties in the management of Sthoulya. The Nighantus—Ayurvedic lexicons such as Bhavaprakasha, Dhanvantari Nighantu, and Raj Nighantu—enumerate various herbs known for these effects. Notable examples include Triphala, Guduchi, Haritaki, Mustaka, Chitraka, and Vrikshamla. These herbs act through multiple mechanisms such as enhancing Agni (digestive fire), promoting lipolysis, regulating appetite, and correcting metabolic imbalances.This review critically evaluates the therapeutic potential of Lekhana and Medohara herbs from classical sources and correlates their pharmacodynamics with modern scientific evidence. The integration of Ayurvedic principles with modern pharmacological insights, including studies on anti-obesity, antioxidant, and hypolipidemic properties, suggests a promising, safe, and sustainable approach to obesity management. A multidimensional strategy incorporating diet, lifestyle, and herbal interventions rooted in Ayurveda can significantly contribute to combating the obesity epidemic.
Downloads
References
World Health Organization. Obesity and overweight. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Sharma PV. Charaka Samhita (Text with English Translation). Vol 1–4. Varanasi: Chaukhambha Orientalia; 2014.
Sharma PV. Sushruta Samhita (With English Translation). Vol I–III. Varanasi: Chaukhambha Vishvabharati; 2012.
Vagbhata. Ashtanga Hridaya. Sutrasthana 15/8. Edited by Harishastri Paradkar. Varanasi: Chaukhamba Sanskrit Sansthan; 2016.
Sharma PV. Dravyaguna Vijnana, Vol. 1. Varanasi: Chaukhamba Bharati Academy; 2014.
Bhavamishra. Bhavaprakasha Nighantu. Guduchyadi Varga. Varanasi: Chaukhamba Bharati; 2011.
Dhanvantari Nighantu. Edited by Acharya Priyavrat Sharma. Varanasi: Chaukhamba Orientalia; 2007.
Raja Nighantu of Narahari Pandita. Dravyaguna Sangraha. Varanasi: Chaukhamba Krishnadas Academy; 2013.
Bhavaprakasha Nighantu. Haritakyadi Varga. Varanasi: Chaukhamba Krishnadas Academy; 2009.
Raja Nighantu. Amlavarga. Edited by Dr. Indradev Tripathi. Varanasi: Chaukhamba Surbharti Prakashan; 2002.
Bhavaprakasha Nighantu. Haridradivarga. Varanasi: Chaukhamba Bharati Academy; 2015.
Urizar NL, Moore DD. Guggulipid: a natural cholesterol-lowering agent. Annu Rev Nutr. 2003; 23:303–313.
Saleem A, Husheem M, Härkönen P, Pihlaja K. Inhibition of cancer cell growth by crude extract and pure compounds of Terminalia chebula Retz. BMC Complement Altern Med. 2002; 2:10.
Kumar A, Singh A, et al. Clinical efficacy of Triphala in obesity: A double-blind, randomized placebo-controlled trial. AYU. 2012;33(2):224–229.
Singh S, Taneja M, Majumdar DK. Biological activities of plumbagin: A review. Fitoterapia. 2003;74(6):559–574.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.